UCSF Magazine spotlights Dr. Shawn Hervey-Jumper, a neurosurgeon who specializes in awake brain surgery, in which patients are alert and engaged during parts of the procedure in order to prevent severe brain damage
The transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much as possible soon after diagnosis, according to the results of a study led by UC San Francisco.
This has been a year of innovation and achievement at the Helen Diller Family Comprehensive Cancer Center. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and families, community groups, and government and industry partners to improve the quality of cancer prevention, treatment, and survivorship. As the year winds down, we take a moment to reflect on some highlights.
Bitopic Inhibitors May Lay Foundation for New Approach to Disease Treatment
UCSF Researchers Identify the Cellular Source of Recurrent Glioma
Novel Immunotherapy Pumps Out Cancer-Killing Cytokines Only Within the Tumor
Dr. Lawrence Fong, Cancer Immunotherapy Program lead at UCSF, joins patients advocates to discuss the advantages and challenges of harnessing the power of cellular therapy in the latest CureTalks podcast.
Using new machine learning techniques, researchers at UC San Francisco, in collaboration with a team at IBM Research, have developed a virtual molecular library of thousands of “command sentences” for cells, based on combinations of “words” that guided engineered immune cells to seek out and tirelessly kill cancer cells.